Motaleb, M., Othman, A., Ibrahim, I., Moustafa, M. (2021). Preparation and Biological Evaluation of Iodopromazine as a Radiopharmaceutical Model for Brain Imaging. Benha Journal of Applied Sciences, 6(1), 231-236. doi: 10.21608/bjas.2021.169114
M.A. Motaleb; A.M. Othman; I.T. Ibrahim; M.E. Moustafa. "Preparation and Biological Evaluation of Iodopromazine as a Radiopharmaceutical Model for Brain Imaging". Benha Journal of Applied Sciences, 6, 1, 2021, 231-236. doi: 10.21608/bjas.2021.169114
Motaleb, M., Othman, A., Ibrahim, I., Moustafa, M. (2021). 'Preparation and Biological Evaluation of Iodopromazine as a Radiopharmaceutical Model for Brain Imaging', Benha Journal of Applied Sciences, 6(1), pp. 231-236. doi: 10.21608/bjas.2021.169114
Motaleb, M., Othman, A., Ibrahim, I., Moustafa, M. Preparation and Biological Evaluation of Iodopromazine as a Radiopharmaceutical Model for Brain Imaging. Benha Journal of Applied Sciences, 2021; 6(1): 231-236. doi: 10.21608/bjas.2021.169114
Preparation and Biological Evaluation of Iodopromazine as a Radiopharmaceutical Model for Brain Imaging
1Hot Lab.Center, Atomic Energy Authority,Cairo, Egypt
2Egypt Second Research Reactor, Atomic Energy Authority,Cairo,Egypt
3Chem Dept.,Faculty of Sciences, Benha Univ., Benha, Egypt
Abstract
This study aimed to prepare a novel radiopharmaceutical for the detection of brain disorders at early stages in susceptible patients.Promazine hydrochloride was labeled with 125I by direct electrophilic substitution reaction with high labeling yields of 92.6 ± 3.24 %. The labeling yield and in vitro stability of 125I-promazine were determined by paper electrophoresis, paper chromatography (PC) and High performance liquid chromatography (HPLC). In vitro studies showed that the highest radiochemical yield of 125I-promazine (92.6±3.24%) was stable up to 6 h. Biodistribution studies showed that maximum uptakes of 125I-promazine in the brain of mice was 5.4 ± 0.18 % injected dose/g after 30 min post-injectionwhich is higher than that of 99mTc-HMPAO and 99mTc-ECD (2.25 and 4.7 %, respectively), so this confirms the high specificity and selectivity of this radiotracer for brain and could be used for brain imaging instead of the commercially available 99mTc-HMPAOand 99mTc-ECD.